课题基金 / 基金详情

Training in Drug Abuse Research: Behavior and Neurobiology

Training in Drug Abuse Research: Behavior and Neurobiology
药物滥用研究培训:行为和神经生物学
批准号:
8266367
负责人:
CHARLES P FRANCE
金额:
$15.72万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2016-06-30

项目摘要

项目成果

CHARLES P FRANCE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This new application entitled "Training in drug abuse research: behavior and neurobiology" requests five years of funding to support a maximum of four postdoctoral fellows per year for interdisciplinary training in drug and alcohol abuse. Fellows primarily engaged in drug and alcohol research take two required courses and attend seminars, journal clubs, an annual retreat, and monthly chalk talks. Fellows will receive training in research and experimental design while participating in collaborative projects spanning at least two laboratories with different expertise and techniques. Training in translational investigation occurs in studies spanning molecular, animal, and human research. Scheduled activities provide career development, preparation for seeking an independent position, and training in the responsible conduct of research. Drug and alcohol abuse research and education at the University of Texas Health Science Center at San Antonio (UTHSCSA) is growing rapidly and the proposed postdoctoral training program is the first step in establishing an NIH-supported program that eventually will include predoctoral training as well. A Program Director with extensive mentoring and research experience will be assisted by Internal and External Advisory Committees. Participating NIH-supported faculty include senior and junior investigators who collectively have research expertise in the following areas in drug and alcohol abuse: molecular and receptor pharmacology; biochemical and neurochemical pharmacology; electrophysiology; preclinical behavioral pharmacology; and clinical trials. This program provides rigorous interdisciplinary training in behavioral and neurobiological research, thereby addressed a national demand for addiction scientists who can succeed in the current translational research environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Methocinnamox (MCAM): A novel opioid receptor antagonist
A novel opioid receptor antagonist for treating abuse and overdose
A novel opioid receptor antagonist for treating abuse and overdose
Methocinnamox (MCAM): A novel õ-opioid receptor antagonist for opioid use disorders
海外基金